ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00274300
Recruitment Status : Completed
First Posted : January 10, 2006
Last Update Posted : January 29, 2007
Sponsor:
Information provided by:
PowderMed

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : July 2005